Tumor | METTL3 (n = 60) | χ2 | P value | AKR1B10 (n = 44) | χ2 | P value | ||
---|---|---|---|---|---|---|---|---|
Low | High | Low | High | |||||
Age | Â | Â | 0.06787 | 0.7945 | Â | Â | 1.245 | 0.2645 |
  < 60 | 16 | 18 | 15 | 13 | ||||
  ≥ 60 | 14 | 12 | 5 | 11 | ||||
Gender | Â | Â | 0.2820 | 0.5954 | Â | Â | 2.146 | 0.1430 |
 Female | 10 | 13 | 12 | 8 | ||||
 Male | 20 | 17 | 8 | 16 | ||||
TNM stage | Â | Â | 4.565 | 0.03263 | Â | Â | 1.426 | 0.2324 |
 T1–T2 | 27 | 19 | 18 | 17 | ||||
 T3–T4 | 3 | 11 | 2 | 7 | ||||
Metastasis | Â | Â | 1.404 | 0.2361 | Â | Â | 0.3536 | 0.5521 |
 Yes | 0 | 3 | 1 | 1 | ||||
 No | 30 | 27 | 19 | 23 | ||||
Relapse | Â | Â | 0.1042 | 0.7469 | Â | Â | 0.4596 | 0.4978 |
 Yes | 24 | 24 | 15 | 21 | ||||
 No | 6 | 6 | 5 | 3 | ||||
Greatest tumor diameter (cm) | Â | Â | 0.06944 | 0.7921 | Â | Â | 0.4016 | 0.5263 |
  < 5 | 11 | 13 | 8 | 13 | ||||
  ≥ 5 | 19 | 17 | 12 | 11 | ||||
Tumor-free survival (month) | Â | Â | 0.6027 | 0.4376 | Â | Â | 0.1291 | 0.7194 |
  < 4 | 12 | 16 | 12 | 12 | ||||
  ≥ 4 | 18 | 14 | 8 | 12 |